-
Company Profile
Curis Inc – Company Profile
Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating cancers with substantial unmet medical need. The company’s lead product Erivedge has been developed in collaboration with F. Hoffmann-La Roche Ltd and Genentech, which is commercialized for the treatment of advanced basal cell carcinoma (BCC). The product is approved for use in patients with advanced BCC in the US, European Union (EU), Australia and several other countries. The company has four drug...
Add to Basket -
Sector Analysis
PharmaPoint: Migraine – Global Drug Forecast and Market Analysis to 2026
Migraine is a complex neurological condition, characterized by frequent headaches that can last between four and 72 hours. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. In most cases, migraine is associated with symptoms such as photophobia, phonophobia, osmophobia, nausea, vomiting, loss of appetite, and sometimes sensory disturbances. The market is currently split into acute and preventative segments, with the majority of drugs used in treatment genericized across the 7MM (US,...
-
Sector Analysis
Consumer and Market Insights: Personal Hygiene Market in India
Of the three categories analyzed, Anti-Perspirants will be the fastest growing category, registering a CAGR of 17.8% during 2015-2020 Male population accounted for the majority of Bath & Shower Products consumption in India Personal Hygiene market in India accounted for more than one fifth of the overall Cosmetics & Toiletries sales during 2011-2014 The Personal Hygiene market in the country is competitive and is led by market players such as Vini Cosmetics and Unilever PLC